SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-036105
Filing Date
2022-03-21
Accepted
2022-03-21 16:06:00
Documents
1
Period of Report
2022-03-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2210039-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2210039-1_4seq1.xml 4 3076
  Complete submission text file 0001104659-22-036105.txt   4739
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICLAS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Branning Todd P. (Reporting) CIK: 0001765274 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 22755783